YKL-40 levels in CSF are elevated particularly in neurodegenerative and neuroinflammatory diseases such as Alzheimer’s disease [22] and multiple sclerosis (MS) [23, 24]. This evidence concerns the gene CHI3L1 and early-onset autosomal dominant Alzheimer disease.